KRTL BioTech

Op-ed: Traditional 60/40 portfolio has actually reached its expiration date

Op-ed: Traditional 60/40 portfolio has actually reached its expiration date

The traditional 60/40 portfolio will likely neither grow in excess of inflation nor provide much downside protection.